Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717―454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitorSIKARIA, Swati; HEIM-HALL, Josefine; DIAZ, Elizabeth H et al.Targeted oncology. 2014, Vol 9, Num 1, pp 73-79, issn 1776-2596, 7 p.Article

Adénocarcinome primitif de la vessieAUDENET, F; VERKARRE, V.Correspondances en onco-urologie. 2014, Vol 5, Num 3, pp 104-105, issn 2110-087X, 2 p.Article

Sarcomes de la vessieCASSIER, P.Correspondances en onco-urologie. 2014, Vol 5, Num 3, pp 108-109, issn 2110-087X, 2 p.Article

A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growthLI, D; WEI, X; XIE, K et al.British journal of cancer. 2014, Vol 111, Num 1, pp 68-77, issn 0007-0920, 10 p.Article

Advances in cancer epidemiology in JapanTANAKA, Hideo.International journal of cancer (Print). 2014, Vol 134, Num 4, pp 747-754, issn 0020-7136, 8 p.Article

Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1KERL, Kornelius; MORENO, Natalia; SCHÜLLER, Ulrich et al.International journal of cancer (Print). 2014, Vol 135, Num 4, pp 989-995, issn 0020-7136, 7 p.Article

Association Between Hypogonadism, Symptom Burden, and Survival in Male Patients With Advanced CancerDEV, Rony; HUI, David; DEL FABBRO, Egidio et al.Cancer. 2014, Vol 120, Num 10, pp 1586-1593, issn 0008-543X, 8 p.Article

Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivativesWONGTRAKOONGATE, P; LI, J; ANDREWS, P. W et al.British journal of cancer. 2014, Vol 110, Num 8, pp 2131-2138, issn 0007-0920, 8 p.Article

Cancer Genomics and Inherited RiskSTADLER, Zsofia K; SCHRADER, Kasmintan A; VIJAI, Joseph et al.Journal of clinical oncology. 2014, Vol 32, Num 7, pp 687-698, issn 0732-183X, 12 p.Article

Circulating 25-hydroxyvitamin D Levels and Prognosis among Cancer Patients: A Systematic ReviewTORIOLA, Adetunji T; NHI NGUYEN; SCHEITLER-RING, Kristen et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 6, pp 917-933, issn 1055-9965, 17 p.Article

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk AssessmentKURIAN, Allison W; HARE, Emily E; CARGILL, Michele et al.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2001-2009, issn 0732-183X, 9 p.Article

Demographic, socioeconomic, disease history, dietary and lifestyle cancer risk factors associated with alcohol consumptionTOUVIER, Mathilde; DRUESNE-PECOLLO, Nathalie; KESSE-GUYOT, Emmanuelle et al.International journal of cancer (Print). 2014, Vol 134, Num 2, pp 445-459, issn 0020-7136, 15 p.Article

Developing an Objective Marker to Optimize Patient Selection and Predict Survival Benefit in Early-Phase Cancer TrialsSTAVRAKA, Chara; PINATO, David J; TURNBULL, Samantha J et al.Cancer. 2014, Vol 120, Num 2, pp 262-270, issn 0008-543X, 9 p.Article

Development and Validation of Risk Models and Molecular Diagnostics to Permit Personalized Management of CancerXIA PU; YUANQING YE; XIFENG WU et al.Cancer. 2014, Vol 120, Num 1, pp 11-19, issn 0008-543X, 9 p.Article

Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cellsSHENGHONG ZHANG; BIHUI ZHONG; HOFFMAN, Andrew R et al.International journal of cancer (Print). 2014, Vol 134, Num 7, pp 1583-1594, issn 0020-7136, 12 p.Article

Epigenetic targets and drug discovery. Part 1: Histone methylationYANLI LIU; KE LIU; SU QIN et al.Pharmacology & therapeutics (Oxford). 2014, Vol 143, Num 3, pp 275-294, issn 0163-7258, 20 p.Article

Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscleMIRZA, K. A; TISDALE, M. J.British journal of cancer. 2014, Vol 111, Num 5, pp 903-908, issn 0007-0920, 6 p.Article

Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell linesWEI LIU; LI LI; WEIDONG LI et al.International journal of cancer (Print). 2014, Vol 135, Num 12, pp 2795-2803, issn 0020-7136, 9 p.Article

Hepatocyte Nuclear Factor-1β Is Not a Specific Marker of Clear Cell Carcinoma in Serous EffusionsDAVIDSON, Ben.Cancer cytopathology. 2014, Vol 122, Num 2, pp 153-158, issn 1934-662X, 6 p.Article

Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patientsJIE HU; ZHENG WANG; QIU, Shuang-Jian et al.International journal of cancer (Print). 2014, Vol 135, Num 5, pp 1187-1194, issn 0020-7136, 8 p.Article

In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16ACCARDI, Luisa; PAOLINI, Francesca; MANDARINO, Angela et al.International journal of cancer (Print). 2014, Vol 134, Num 11, pp 2742-2747, issn 0020-7136, 6 p.Article

Infections Among Long-Term Survivors of Childhood and Adolescent Cancer: A Report From the Childhood Cancer Survivor StudyPERKINS, Joanna L; YAN CHEN; HARRIS, Anne et al.Cancer. 2014, Vol 120, Num 16, pp 2514-2521, issn 0008-543X, 8 p.Article

Inflammasome: Cancer's friend or foe?TERLIZZI, Michela; CASOLARO, Vincenzo; PINTO, Aldo et al.Pharmacology & therapeutics (Oxford). 2014, Vol 143, Num 1, pp 24-33, issn 0163-7258, 10 p.Article

Lack of Reduction in Racial Disparities in Cancer-Specific Mortality Over a 20-Year PeriodAIZER, Ayal A; WILHITE, Tyler J; CHEN, Ming-Hui et al.Cancer. 2014, Vol 120, Num 10, pp 1532-1539, issn 0008-543X, 8 p.Article

Late morbidity leading to hospitalization among 5-year survivors of young adult cancer: A report of the childhood, adolescent and young adult cancer survivors research programYANG ZHANG; LORENZI, Maria F; GODDARD, Karen et al.International journal of cancer (Print). 2014, Vol 134, Num 5, pp 1174-1182, issn 0020-7136, 9 p.Article